Abstract
Background
Hypertension disorders in pregnancy (HDP) were common complications in women with systemic lupus erythematosus (SLE). However, the impact of HDP and the measures to prevent HDP-related fetal adverse pregnancy outcomes (APOs) remained to be explored.
Methods
A multicenter retrospective study of 342 pregnant women with SLE was performed. Variables related to SLE and APOs were recorded. Fetal development was evaluated by umbilical artery Doppler ultrasonography.
Results
HDP was diagnosed in 45 (13.2%) patients, including pre-eclampsia in 42 and gestational hypertension in 3. Patients with HDP had higher incidence of preterm birth (71.1% vs 20.9%, P < 0.001), intrauterine growth retardation (IUGR) (37.8% vs 11.8%, P < 0.001), low-birth-weight infants (62.2% vs 17.2%, P < 0.001), and very-low-birth-weight infants (37.8% vs 2.7%, P < 0.001), compared with lupus patients without HDP. A total of 35 (77.8%) HDP patients had disease activation during pregnancy. All the events occurred during the second and third trimesters, mainly presenting as moderate-to-high activity (65.7%). Active disease [odds ratios (OR) = 3.9, 95% confidential interval (CI) 1.5–9.7, P = 0.004] and positive anticardiolipin (aCL) antibody (OR = 7.6, 95% CI 2.7–18.6, P < 0.001) were independent risk factors for HDP in lupus patients. Doppler RI and S/D ratio predicted APOs in patients with HDP. The optimal cut-off values for RI and S/D ratio were 0.7 (sensitivity 48.1%, specificity 53.3%) and 3.4 (sensitivity 66.7%, specificity 100%), respectively.
Conclusions
HDP was a common pregnant complication and caused various fetal and maternal adverse outcomes in patients with SLE. Umbilical artery Doppler ultrasonography was effective in predicting fetal APOs in lupus patients with HDP.
Key Points • HDP induced preterm birth, IUGR, low-birth-weight infants, and very-low-birth-weight infants in patients with SLE. • HDP led to lupus activation during the second and third trimesters. • Disease activation and aCL positivity were predictors for HDP. • RI and S/D ratio from umbilical artery Doppler predicted APOs in patients with HDP. |
Similar content being viewed by others
References
Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM (2017) Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis 76(12):2009–2016. https://doi.org/10.1136/annrheumdis-2017-211663
Bundhun PK, Soogund MZ, Huang F (2017) Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001–2016. J Autoimmun 79:17–27. https://doi.org/10.1016/j.jaut.2017.02.009
Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Garabet L, Salmon JE (2015) Predictors of pregnancy outcomes in patients with lupus: a cohort study. Ann Intern Med 163(3):153–163. https://doi.org/10.7326/M14-2235
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R (2011) Pre-eclampsia. Lancet 376(9741):631–644. https://doi.org/10.1016/S0140-6736(10)60279-6
Flenady V, Koopmans L, Middleton P, Frøen JF, Smith GC, Gibbons K, Coory M, Gordon A, Ellwood D, McIntyre HD, Fretts R, Ezzati M (2011) Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 377(9774):1331–1340. https://doi.org/10.1016/S0140-6736(10)62233-7
Moroni G, Doria A, Giglio E, Imbasciati E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, Gatto M, de Liso F, Grossi C, Meroni PL, Cabiddu G, Messa P, Ravani P, Mosca M (2016) Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. J Autoimmun 74:194–200. https://doi.org/10.1016/j.jaut.2016.06.012
(2000) Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183(1):S1–S22
Tanaka M, Jaamaa G, Kaiser M, Hills E, Soim A, Zhu M, Shcherbatykh IY, Samelson R, Bell E, Zdeb M, McNutt LA (2007) Racial disparity in hypertensive disorders of pregnancy in New York state: a 10-year longitudinal population-based study. Am J Public Health 97(1):163–170
Moroni G, Doria A, Giglio E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, de Liso F, Matinato C, Grossi C, Gatto M, Castellana P, Limardo M, Meroni PL, Messa P, Ravani P, Mosca M (2016) Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. J Autoimmun 74:6–12. https://doi.org/10.1016/j.jaut.2016.07.010
Wigren M, Nilsson J, Kaplan MJ (2015) Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention. J Intern Med 278:494–506
Vest AR, Cho LS (2014) Hypertension in pregnancy. Curr Atheroscler Rep 16(5):395–506. https://doi.org/10.1111/joim.12357
Siddiqui TS, Asim A, Ali S, Siddiqui TS, Tariq A (2014) Comparison of perinatal outcome in growth restricted fetuses retaining normal umbilical artery Doppler flow to those with diminished end-diastolic flow. J Ayub Med Coll Abbottabad 26(2):221–224
Zhan Z, Zhan Y, Lao M, Yang X, Wang X, Chen D (2018) Role of foetal umbilical artery Doppler on prediction of adverse pregnancy outcomes in patients with systemic lupus erythematosus. Clin Exp Rheumatol 36(5):871–878
Altorjay ÁT, Surányi A, Nyári T, Németh G (2017) Use of placental vascularization indices and uterine artery peak systolic velocity in early detection of pregnancies complicated by gestational diabetes, chronic or gestational hypertension, and preeclampsia at risk. Croat Med J 58(2):161–169
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
Chinese SLE Treatment and Research Group (2015) Chinese recommendations for perinatal management in women with SLE. National Medical Journal of China 95:1056–1060
Buyon JP, Kalunian KC, Ramsey-Goldman R, Petri MA, Lockshin MD, Ruiz-Irastorza G, Khamashta M (1999) Assessing disease activity in SLE patients during pregnancy. Lupus 8(8):677–684
Ruperto N, Hanrahan LM, Alarcón GS, Belmont HM, Brey RL, Brunetta P, Buyon JP, Costner MI, Cronin ME, Dooley MA, Filocamo G, Fiorentino D, Fortin PR, Franks AG Jr, Gilkeson G, Ginzler E, Gordon C, Grossman J, Hahn B, Isenberg DA, Kalunian KC, Petri M, Sammaritano L, Sánchez-Guerrero J, Sontheimer RD, Strand V, Urowitz M, von Feldt JM, Werth VP, Merrill JT, Lupus Foundation of America, Inc. International Flare Consensus Initiative (2011) International Flare Consensus Initiative. International consensus for a definition of disease flare in lupus. Lupus 20(5):453–462. https://doi.org/10.1177/0961203310388445
Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20(1):IX–XIV
Yang YY, Fang YH, Wang X, Zhang Y, Liu XJ, Yin ZZ (2018) A retrospective cohort study of risk factors and pregnancy outcomes in 14,014 Chinese pregnant women. Medicine (Baltimore) 97(33):e11748. https://doi.org/10.1097/MD.0000000000011748
Ye C, Ruan Y, Zou L, Li G, Li C, Chen Y, Jia C, Megson IL, Wei J, Zhang W (2014) The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes. PLoS One 9(6):e100180. https://doi.org/10.1371/journal.pone.0100180
Phansenee S, Sekararithi R, Jatavan P, Tongsong T (2018) Pregnancy outcomes among women with systemic lupus erythematosus: a retrospective cohort study from Thailand. Lupus 27(1):158–164. https://doi.org/10.1177/0961203317721353
Koh JH, Ko HS, Lee J, Jung SM, Kwok SK, Ju JH, Park SH (2015) Pregnancy and patients with preexisting lupus nephritis: 15 years of experience at a single center in Korea. Lupus 24(7):764–772. https://doi.org/10.1177/0961203315572715
Zhan Z, Yang Y, Zhan Y, Chen D, Liang L, Yang X (2017) Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus. PLoS One 2017 12(4):e0176457. https://doi.org/10.1371/journal.pone.0176457
Chakravarty EF, Nelson L, Krishnan E (2006) Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 54(3):899–907
Macdonald-Wallis C, Tilling K, Fraser A, Nelson SM, Lawlor DA (2014) Associations of blood pressure change in pregnancy with fetal growth and gestational age at delivery: findings from a prospective cohort. Hypertension 64:36–44. https://doi.org/10.1161/HYPERTENSIONAHA.113.02766
Jara LJ, Medina G, Cruz-Dominguez P, Navarro C, Vera-Lastra O, Saavedra MA (2014) Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res 60(2–3):184–192. https://doi.org/10.1007/s12026-014-8577-1
Jianjun Z, Yali H, Zhiqun W, Mingming Z, Xia Z (2010) Imbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in preeclampsia. Am J Reprod Immunol 63(1):38–45. https://doi.org/10.1111/j.1600-0897.2009.00763.x
Small HY, Nosalski R, Morgan H, Beattie E, Guzik TJ, Graham D, Delles C Role of tumor necrosis factor-α and natural killer cells in uterine artery function and pregnancy outcome in the stroke-prone spontaneously hypertensive rat. Hypertension 68(5):1298–1307
Munroe ME, Vista ES, Merrill JT, Guthridge JM, Roberts VC, James JA (2017) Pathways of impending disease flare in African-American systemic lupus erythematosus patients. J Autoimmun 78:70–78. https://doi.org/10.1016/j.jaut.2016.12.005
Jorgensen KT, Nielsen NM, Pedersen BV, Guthridge JM, Roberts VC, James JA (2012) Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a Danish population-based cohort. J Autoimmun 38(2–3):120–128. https://doi.org/10.1016/j.jaut.2011.10.002
Chen D, Lao M, Zhang J, Zhan Y, Li W, Cai X, Zhan Z Fetal and maternal outcomes of planned pregnancy in patients with systemic lupus erythematosus: a retrospective multicenter study. J Immunol Res:2413637. https://doi.org/10.1155/2018/2413637
Larosa M, Del Ross T, Calligaro A, Favaro M, Zanatta E, Iaccarino L, Doria A (2019) Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus. Expert Rev Clin Immunol 15(6):617–627. https://doi.org/10.1080/1744666X.2019.1601557
Xia Y, Kellems RE (2013) Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond. Circ Res 113(1):78–87. https://doi.org/10.1161/CIRCRESAHA.113.300752
Wang W, Irani RA, Zhang Y, Ramin SM, Blackwell SC, Tao L, Kellems RE, Xia Y (2012) Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia. Hypertension 60(3):712–721. https://doi.org/10.1161/HYPERTENSIONAHA.112.191817
Hunt B, Khamashta M (2000) Antiphospholipid antibodies and the endothelium. Curr Rheumatol Rep 2(3):252–255
Raschi E, Testoni C, Borghi M, Fineschi S, Meroni PL (2003) Endothelium activation in the anti-phospholipid syndrome. Biomed Pharmacother 57(7):282–286
Meroni P, Raschi E, Testoni C, Parisio A, Borghi MO (2004) Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun Rev 3(7–8):510–515
Riboldi P, Gerosa M, Raschi E, Testoni C, Meroni P (2003) Endothelium as a target for antiphospholipid antibodies. Immunobiology 207(1):29–36
Ruiz-Irastorza G, Khamashta M (2011) Lupus and pregnancy: integrating clues from the bench and bedside. Eur J Clin Investig 41(6):672–678. https://doi.org/10.1111/j.1365-2362.2010.02443.x
Chakravarty EF, Colón I, Langen ES, Nix DA, El-Sayed YY, Genovese MC, Druzin ML (2005) Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 192(6):1897–1904
Vest AR, Cho LS (2014) Hypertension in pregnancy. Curr Atheroscler Rep 16(3):395. https://doi.org/10.1007/s11883-013-0395-8
Le Thi HD, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoat N, Andreu MR, Lefebvre G, Piette JC (2006) The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 45(3):332–338
Gómez-Guzmán M, Jiménez RI, Romero M, Sánchez M, Zarzuelo MJ, Gómez-Morales M, O'Valle F, López-Farré AJ, Algieri F, Gálvez J, Pérez-Vizcaino F, Sabio JM, Duarte J (2014) Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus. Hypertension 64(2):330–337. https://doi.org/10.1161/HYPERTENSIONAHA.114.03587
Seo MR, Chae J, Kim YM, Cha HS, Choi SJ, Oh S, Roh CR (2019) Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia. Lupus:961203319843343. https://doi.org/10.1177/0961203319843343
Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A (2017) EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 76(3):476–485. https://doi.org/10.1136/annrheumdis-2016-209770
Martinez-Sanchez N, Pérez-Pinto S, Robles-Marhuenda Á, Arnalich-Fernández F, Martín Cameán M, Hueso Zalvide E, Bartha JL (2017) Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study. Immunol Res 65(2):487–494. https://doi.org/10.1007/s12026-016-8888-5
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Disclosures
None.
Financial support
This project was supported by grants from the National Natural Science Foundation of China (81601403, 81603435), the Natural Science Foundation of Guangdong Province (2018A0303130294), and the Medical Scientific Research Foundation of Guangdong Province (A2018027).
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, D., Lao, M., Cai, X. et al. Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study. Clin Rheumatol 38, 3501–3509 (2019). https://doi.org/10.1007/s10067-019-04696-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-019-04696-x